Literature DB >> 21696383

Genotype-phenotype correlation in colorectal polyposis.

K F Newton1, E K L Mallinson, J Bowen, F Lalloo, T Clancy, J Hill, D G R Evans.   

Abstract

Familial adenomatous polyposis (FAP) has been divided into three clinical subtypes: mild, classical and severe. This study aimed to investigate for a correlation between genotype and phenotype. A codon-specific survival difference is unknown. A retrospective longitudinal study of 492 patients on the Manchester Polyposis Registry was conducted. Patients were grouped according to genotypes: 0, unknown mutation; 1, adenomatous polyposis coli (APC) 0-178 (and 312-412 of exon 9); 2, APC >1550; 3, APC 179-1249; 4, APC 1250-1549; and 5, MutYH. Date of onset of polyposis, incidence of colorectal cancer (CRC), survival and actuarial time to surgery were calculated. Median age of onset of polyposis for genotype 0 was 20.3 years, genotype 1 35.6 years, genotype 2 32.2, genotype 3 15.9 years, and genotype 4 14.8 years (p < 0.0001). Age of onset of CRC was similar between genotypes. Median survival for genotype 0 was 56.6 years, genotype 1 74.9 years, genotype 2 61.0 years, genotype 3 63.0 years, genotype 4 48.1 years, and genotype 5 69.7 years (p = 0.003). This survival difference was also seen when patients who underwent screening and those who did not were analysed separately. Survival in the screened population was 53.9 years in genotype 4 and 72.9 years in genotype 3. Patients with genotype 4 (APC 1249-1549) have a significantly worse survival despite screening and early prophylactic surgery. This analysis supports a genotype-phenotype correlation. Patients with a mutation APC 1249-1549 develop polyposis at an early age and have a worse survival. Patients with a mutation APC 0-178 or 312-412 develop polyposis later and have an improved survival. This survival difference has not previously been documented.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21696383     DOI: 10.1111/j.1399-0004.2011.01740.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).

Authors:  Winifred Lo; Bin Zhu; Arvind Sabesan; Ho-Hsiang Wu; Astin Powers; Rebecca A Sorber; Sarangan Ravichandran; Ina Chen; Lucas A McDuffie; Humair S Quadri; Joal D Beane; Kathleen Calzone; Markku M Miettinen; Stephen M Hewitt; Christopher Koh; Theo Heller; Sholom Wacholder; Udo Rudloff
Journal:  J Med Genet       Date:  2019-02-11       Impact factor: 6.318

Review 2.  Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes.

Authors:  Holger Eduard Vogelsang
Journal:  Visc Med       Date:  2019-07-16

3.  Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.

Authors:  Yoshihiko Miyamoto; Naoki Muguruma; Tetsuo Kimura; Koichi Okamoto; Masahiro Sogabe; Hiroshi Miyamoto; Seiya Kohno; Masahiko Nakasono; Hiroshige Hayashi; Yoshimi Bando; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-05-12

4.  Detection of APC mosaicism by next-generation sequencing in an FAP patient.

Authors:  Kiyoshi Yamaguchi; Mitsuhiro Komura; Rui Yamaguchi; Seiya Imoto; Eigo Shimizu; Shinichi Kasuya; Tetsuo Shibuya; Seira Hatakeyama; Norihiko Takahashi; Tsuneo Ikenoue; Keisuke Hata; Giichiro Tsurita; Masaru Shinozaki; Yutaka Suzuki; Sumio Sugano; Satoru Miyano; Yoichi Furukawa
Journal:  J Hum Genet       Date:  2015-02-26       Impact factor: 3.172

5.  Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.

Authors:  Rachel A Levy; Vanessa W Hui; Rupa Sood; Stephanie Fish; Arnold J Markowitz; Richard J Wong; José G Guillem
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 6.  Familial colon cancer syndromes: an update of a rapidly evolving field.

Authors:  Swati G Patel; Dennis J Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2012-10

7.  Chemoprevention in patients with genetic risk of colorectal cancers.

Authors:  Christina M Laukaitis; Steven H Erdman; Eugene W Gerner
Journal:  Colorectal Cancer       Date:  2012

8.  Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations.

Authors:  Dai-Xiang Liao; Bing Li; Xue-Mei Du; Jun-Hui Yu; Hong Chang; Zhi-Qiang Wu; Hao-Jie Hao; You-Xin Wang; Wei-Dong Han; Shu-Jun Cheng; Cheng-Hua Luo
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

9.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

10.  Mutational spectrum of the APC and MUTYH genes and genotype-phenotype correlations in Brazilian FAP, AFAP, and MAP patients.

Authors:  Giovana Tardin Torrezan; Felipe Cavalcanti Carneiro da Silva; Erika Maria Monteiro Santos; Ana Cristina Victorino Krepischi; Maria Isabel Waddington Achatz; Samuel Aguiar; Benedito Mauro Rossi; Dirce Maria Carraro
Journal:  Orphanet J Rare Dis       Date:  2013-04-05       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.